Grimes & Company, Inc. Novartis Ag Transaction History

Grimes & Company, Inc.

  • $3.43 Billion
  • Q4 2024

A detailed history of Grimes & Company, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Grimes & Company, Inc. holds 4,487 shares of NVS stock, worth $448,565. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,487
Previous 4,571 1.84%
Holding current value
$448,565
Previous $525,000 16.95%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025
SELL
$96.78 - $117.18 $8,129 - $9,843
-84 Reduced 1.84%
4,487 $436,000
Q3 2024

Oct 22, 2024
BUY
$106.13 - $120.89 $1,698 - $1,934
16 Added 0.35%
4,571 $525,000
Q2 2024

Jul 22, 2024
SELL
$92.57 - $107.37 $922,645 - $1.07 Million
-9,967 Reduced 68.63%
4,555 $484,000
Q1 2024

Apr 17, 2024
SELL
$95.27 - $108.47 $45,539 - $51,848
-478 Reduced 3.19%
14,522 $1.4 Million
Q4 2023

Jan 24, 2024
SELL
$92.27 - $101.54 $72,431 - $79,708
-785 Reduced 4.97%
15,000 $1.51 Million
Q3 2023

Oct 19, 2023
SELL
$94.73 - $105.13 $135,084 - $149,915
-1,426 Reduced 8.29%
15,785 $1.61 Million
Q2 2023

Jul 19, 2023
SELL
$92.52 - $104.91 $11.3 Million - $12.8 Million
-121,877 Reduced 87.63%
17,211 $1.74 Million
Q1 2023

Apr 20, 2023
SELL
$80.03 - $92.81 $288,348 - $334,394
-3,603 Reduced 2.53%
139,088 $12.8 Million
Q4 2022

Jan 25, 2023
BUY
$75.55 - $92.52 $3,399 - $4,163
45 Added 0.03%
142,691 $0
Q3 2022

Oct 28, 2022
BUY
$74.61 - $87.26 $100,052 - $117,015
1,341 Added 0.95%
142,646 $10.8 Million
Q2 2022

Jul 22, 2022
BUY
$80.52 - $93.75 $188,980 - $220,031
2,347 Added 1.69%
141,305 $11.9 Million
Q1 2022

May 06, 2022
BUY
$80.11 - $90.62 $3.86 Million - $4.37 Million
48,186 Added 53.08%
138,958 $12.2 Million
Q4 2021

Feb 01, 2022
BUY
$79.7 - $88.13 $175,738 - $194,326
2,205 Added 2.49%
90,772 $7.94 Million
Q3 2021

Nov 08, 2021
BUY
$81.78 - $95.14 $220,478 - $256,497
2,696 Added 3.14%
88,567 $7.24 Million
Q2 2021

Aug 04, 2021
BUY
$85.24 - $94.15 $152,323 - $168,246
1,787 Added 2.13%
85,871 $7.84 Million
Q1 2021

May 12, 2021
BUY
$83.5 - $98.47 $219,688 - $259,074
2,631 Added 3.23%
84,084 $7.19 Million
Q4 2020

Feb 02, 2021
BUY
$78.07 - $94.43 $115,309 - $139,473
1,477 Added 1.85%
81,453 $7.69 Million
Q3 2020

Nov 12, 2020
BUY
$82.14 - $91.0 $1 Million - $1.11 Million
12,186 Added 17.98%
79,976 $6.95 Million
Q2 2020

Jul 31, 2020
SELL
$80.93 - $91.1 $54,465 - $61,310
-673 Reduced 0.98%
67,790 $5.92 Million
Q1 2020

May 05, 2020
BUY
$70.67 - $99.01 $15,830 - $22,178
224 Added 0.33%
68,463 $5.65 Million
Q4 2019

Feb 05, 2020
BUY
$84.35 - $95.37 $43,608 - $49,306
517 Added 0.76%
68,239 $6.46 Million
Q3 2019

Nov 05, 2019
BUY
$85.54 - $94.26 $100,081 - $110,284
1,170 Added 1.76%
67,722 $5.89 Million
Q2 2019

Jul 30, 2019
BUY
$75.4 - $92.8 $132,251 - $162,771
1,754 Added 2.71%
66,552 $6.08 Million
Q1 2019

May 02, 2019
BUY
$75.32 - $86.15 $4,368 - $4,996
58 Added 0.09%
64,798 $6.23 Million
Q4 2018

Feb 01, 2019
SELL
$73.66 - $82.02 $53,108 - $59,136
-721 Reduced 1.1%
64,740 $5.56 Million
Q3 2018

Nov 09, 2018
SELL
$66.94 - $77.43 $1.2 Million - $1.39 Million
-17,950 Reduced 21.52%
65,461 $5.64 Million
Q2 2018

Aug 10, 2018
SELL
$64.91 - $73.36 $47,384 - $53,552
-730 Reduced 0.87%
83,411 $6.3 Million
Q1 2018

May 07, 2018
BUY
$70.39 - $84.15 $117,762 - $140,782
1,673 Added 2.03%
84,141 $6.8 Million
Q4 2017

Feb 05, 2018
BUY
$72.33 - $77.64 $3.68 Million - $3.95 Million
50,821 Added 160.59%
82,468 $6.92 Million
Q3 2017

Nov 03, 2017
BUY
$74.14 - $77.27 $2.35 Million - $2.45 Million
31,647
31,647 $2.72 Million

Others Institutions Holding NVS

# of Institutions
1,423
Shares Held
130M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $215B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Grimes & Company, Inc. Portfolio

Follow Grimes & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email